Yes, Unisom is an anticholinergic drug. Its active ingredient, doxylamine succinate, is classified as a first-generation antihistamine, and like all drugs in that class, it blocks acetylcholine receptors throughout the body in addition to blocking histamine. On the Anticholinergic Cognitive Burden (ACB) scale, doxylamine scores a 3, the highest possible rating, meaning it has strong anticholinergic activity.
Why an Antihistamine Acts as an Anticholinergic
Doxylamine was designed to block histamine receptors, which is what makes you drowsy and why it works as a sleep aid. But histamine receptors share a similar shape with other receptor types in the nervous system, particularly muscarinic receptors, which respond to the neurotransmitter acetylcholine. Doxylamine binds to those muscarinic receptors too, essentially blocking acetylcholine signaling across multiple organ systems. This isn’t a rare quirk of doxylamine. It’s a known property of all first-generation antihistamines, including diphenhydramine (sold as Benadryl and also used in some Unisom products).
What Anticholinergic Effects Feel Like
Acetylcholine is involved in everything from muscle movement to digestion to memory formation, so blocking it produces a wide range of effects. The most common ones you might notice after taking Unisom include dry mouth, constipation, blurred vision, difficulty urinating, and an increased heart rate. Many people experience the dry mouth and grogginess and assume those are just “sleep aid side effects,” but they’re specifically anticholinergic effects.
In the brain, anticholinergic activity can cause confusion, difficulty concentrating, and impaired short-term memory. These cognitive effects tend to be more pronounced in older adults, whose bodies clear the drug more slowly.
The Dementia Risk Question
The biggest concern with anticholinergic drugs is what happens with long-term, cumulative use. A large nested case-control study published in JAMA Internal Medicine found that people with the highest cumulative exposure to anticholinergic drugs (roughly three or more years of daily use) had 49% higher odds of developing dementia compared to people with minimal exposure. A separate U.S. cohort study found a similar increase of 54%.
Interestingly, when researchers broke the data down by drug type, antihistamines specifically showed a weaker association with dementia (14% higher odds) compared to anticholinergic antidepressants (29% higher) or antiparkinson drugs (52% higher). That antihistamine figure wasn’t statistically significant on its own, meaning the link could have been due to chance. Still, the overall pattern across all anticholinergic drugs is consistent enough that clinical guidelines treat it seriously.
What Clinical Guidelines Say
The American Geriatrics Society’s Beers Criteria, the most widely used guide for medication safety in older adults, lists both doxylamine and diphenhydramine under a strong “avoid” recommendation. The rationale is straightforward: these drugs are highly anticholinergic, the body clears them more slowly with age, and cumulative anticholinergic exposure is associated with increased risk of falls, delirium, and dementia.
The guidelines also note that tolerance develops when these drugs are used regularly for sleep, meaning they become less effective over time while the anticholinergic burden remains. The recommendation applies even to “young-old” adults (typically those in their 60s), not just the very elderly. For younger adults, occasional use is generally considered lower risk, but the ACB score of 3 means doxylamine adds significant anticholinergic load any time you take it.
How Anticholinergic Burden Adds Up
One important concept is that anticholinergic effects are cumulative across all the medications you take. If you’re using Unisom for sleep and also taking another drug with anticholinergic properties (certain allergy medications, bladder medications, or antidepressants), the effects stack. The Beers Criteria specifically warns that using more than one anticholinergic medication increases the risk of cognitive decline, delirium, falls, and fractures. This is why pharmacists and geriatric specialists look at total anticholinergic burden rather than evaluating each drug in isolation.
Sleep Aid Alternatives Without Anticholinergic Activity
If the anticholinergic profile of Unisom concerns you, several sleep aid options work through entirely different pathways. Melatonin receptor agonists target the body’s natural sleep-wake signaling without any anticholinergic effects or abuse potential. Orexin receptor antagonists are a newer class that work by blocking wakefulness-promoting signals in the brain rather than sedating you broadly. Low-dose versions of certain older medications have also been shown to improve sleep time and reduce nighttime awakenings in elderly patients without causing anticholinergic side effects or memory impairment. All of these require a prescription, unlike Unisom, so they involve a conversation with a provider about what’s driving your sleep problems in the first place.
Over-the-counter melatonin supplements are another non-anticholinergic option, though evidence for their effectiveness varies depending on the type of insomnia. They tend to work best for circadian rhythm issues, like jet lag or delayed sleep phase, rather than general difficulty staying asleep.